893 related articles for article (PubMed ID: 34135508)
1. Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells.
Casanova-Acebes M; Dalla E; Leader AM; LeBerichel J; Nikolic J; Morales BM; Brown M; Chang C; Troncoso L; Chen ST; Sastre-Perona A; Park MD; Tabachnikova A; Dhainaut M; Hamon P; Maier B; Sawai CM; Agulló-Pascual E; Schober M; Brown BD; Reizis B; Marron T; Kenigsberg E; Moussion C; Benaroch P; Aguirre-Ghiso JA; Merad M
Nature; 2021 Jul; 595(7868):578-584. PubMed ID: 34135508
[TBL] [Abstract][Full Text] [Related]
2. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
3. Innate immune activation by checkpoint inhibition in human patient-derived lung cancer tissues.
Fan TW; Higashi RM; Song H; Daneshmandi S; Mahan AL; Purdom MS; Bocklage TJ; Pittman TA; He D; Wang C; Lane AN
Elife; 2021 Aug; 10():. PubMed ID: 34406120
[TBL] [Abstract][Full Text] [Related]
4. JAML promotes the antitumor role of tumor-resident CD8
Hao Z; Xin Z; Chen Y; Shao Z; Lin W; Wu W; Lin M; Liu Q; Chen D; Wu D; Wu P
Cancer Lett; 2024 May; 590():216839. PubMed ID: 38570084
[TBL] [Abstract][Full Text] [Related]
5. Using macrophage activation to augment immunotherapy of established tumours.
Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
7. Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE
Che D; Zhang S; Jing Z; Shang L; Jin S; Liu F; Shen J; Li Y; Hu J; Meng Q; Yu Y
Mol Immunol; 2017 Oct; 90():197-210. PubMed ID: 28837884
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.
Vilariño N; Bruna J; Bosch-Barrera J; Valiente M; Nadal E
Cancer Treat Rev; 2020 Sep; 89():102067. PubMed ID: 32682248
[TBL] [Abstract][Full Text] [Related]
9. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
10. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
Bonde AK; Tischler V; Kumar S; Soltermann A; Schwendener RA
BMC Cancer; 2012 Jan; 12():35. PubMed ID: 22273460
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor 2 plays a pro-tumorigenic role in non-small cell lung cancer by limiting anti-tumor activity of CD8
Sarsembayeva A; Kienzl M; Gruden E; Ristic D; Maitz K; Valadez-Cosmes P; Santiso A; Hasenoehrl C; Brcic L; Lindenmann J; Kargl J; Schicho R
Front Immunol; 2022; 13():997115. PubMed ID: 36700219
[TBL] [Abstract][Full Text] [Related]
12. Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells†.
Ampollini L; Madeddu D; Falco A; Frati C; Lorusso B; Graiani G; Saccani F; Gervasi A; Rossetti P; Bonomini S; Gnetti L; Lagrasta CA; Silini EM; Quaini E; Petronini P; Alfieri R; Rusca M; Carbognani P; Quaini F
Eur J Cardiothorac Surg; 2014 Dec; 46(6):e103-12. PubMed ID: 25312525
[TBL] [Abstract][Full Text] [Related]
13. IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines.
Song NY; Li X; Ma B; Willette-Brown J; Zhu F; Jiang C; Su L; Shetty J; Zhao Y; Shi G; Banerjee S; Wu X; Tran B; Nussinov R; Karin M; Hu Y
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35121655
[TBL] [Abstract][Full Text] [Related]
14. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
15. Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer.
Backman M; Strell C; Lindberg A; Mattsson JSM; Elfving H; Brunnström H; O'Reilly A; Bosic M; Gulyas M; Isaksson J; Botling J; Kärre K; Jirström K; Lamberg K; Pontén F; Leandersson K; Mezheyeuski A; Micke P
Eur J Cancer; 2023 May; 185():40-52. PubMed ID: 36963351
[TBL] [Abstract][Full Text] [Related]
16. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment.
Rebelo SP; Pinto C; Martins TR; Harrer N; Estrada MF; Loza-Alvarez P; Cabeçadas J; Alves PM; Gualda EJ; Sommergruber W; Brito C
Biomaterials; 2018 May; 163():185-197. PubMed ID: 29477032
[TBL] [Abstract][Full Text] [Related]
17. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
18. Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer.
Han R; Guo H; Shi J; Wang H; Zhao S; Jia Y; Liu X; Li J; Cheng L; Zhao C; Li X; Zhou C
Eur J Cancer; 2023 Aug; 189():112919. PubMed ID: 37320935
[TBL] [Abstract][Full Text] [Related]
19. CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer.
Zhang M; Yang W; Wang P; Deng Y; Dong YT; Liu FF; Huang R; Zhang P; Duan YQ; Liu XD; Lin D; Chu Q; Zhong B
Nat Commun; 2020 Nov; 11(1):6119. PubMed ID: 33257678
[TBL] [Abstract][Full Text] [Related]
20. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
